CEO Jonathan Cohen to Detail the Company’s Strongest Quarterly Performance Since Commercial Launch of Multi-Cancer Early Detection Testing, Key Takeaways from the Next Generation Dx Summit, and Path to Broader Commercial Adoption Webinar to Be Held Wednesday, September 2, 2026 at 12:00 p.m. Eastern Time; Registration Is Now Open GAITHERSBURG, Md., Aug. 26, 2026 (GLOBE NEWSWIRE) -- 20/20 BioLabs, Inc. (NASDAQ:AIDX) ("20/20 BioLabs" or the "Company"), an early market entrant in AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today announced that it will host an investor webinar on Wednesday, September 2, 2026, at 12:00 p.m. E
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- 20/20 BioLabs to Host Investor Webinar on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity
- Honeywell Aerospace announces participation at upcoming investor conferences
PHOENIX, Aug. 26, 2026 /PRNewswire/ -- Honeywell Aerospace (NASDAQ:HONA) today announced its participation at upcoming investor conferences in September. On Wednesday, September 9, 2026, Jim Currier, Chief Executive Officer of Honeywell Aerospace, will present at the Jefferies Industrials Conference in New York City from 8:10 a.m. - 8:45 a.m. EDT.On Thursday, September 10, 2026, Jim Currier and Josh Jepsen, Chief Financial Officer of Honeywell Aerospace, will attend the Vertical Research Partners Global Industrials Conference in Westbrook, Connecticut.On Tuesday, September 15, 2026, Jim Currier will present at the Morgan Stanley Laguna Conference in Dana Point, California, from 7:00 a.m. - 7
- Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility
The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) production; supports delivery of next-generation pipelineINDIANAPOLIS, Aug. 26, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE:ELAN) today announced the on-time completion of a 25,000-square-foot manufacturing expansion of its Elwood, Kansas manufacturing site. As one of only two animal health companies with mAb solutions on the market today, the expansion further strengthens Elanco's leadership in the biologics space. "When we announced the expansion two years ago, we recognized that executing the most exciting pipe
- FibroBiologics Regains Compliance with Nasdaq Trading Rules
HOUSTON, Aug. 26, 2026 /PRNewswire/ -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics" or the "Company"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced that it received confirmation from The Nasdaq Stock Market LLC ("Nasdaq") on August 25, 2026, informing the Company that it has regained compliance with the bid price requirement in Listing Rule 5550(a)(2). The Company is now in compliance with all Nasdaq listing standards, and its common s
- Leifras Anticipates Benefit from Expanded Trading Access as Nasdaq Plans 23-Hour Weekday Trading
Leifras ADSs to Become More Accessible for Trading, Including During Daytime Hours in JapanTOKYO, Aug. 26, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (NASDAQ:LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports and community engagement and Japan's leading operator of children's sports schools and school club activity support businesses, today announced that its Nasdaq-listed American Depositary Shares ("ADSs") are expected to benefit from the planned expansion of Nasdaq trading hours to 23 hours per weekday starting December 6, 2026. In parallel, certain Japanese online brokerages are expanding access to extended-hours trading in U.S. equities, includ
- Cellebrite Brings Battlefield Intelligence to the Armed Forces with Launch of Portable Tactical Extraction Kit (C-TEK)
Built around Cellebrite's industry-leading digital forensics capabilities, C-TEK helps forward-deployed teams quickly triage data from phones, SIM cards, drones and portable media to advance their missionsTYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 26, 2026 /CNW/ -- Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced the launch of the Cellebrite Tactical Extraction Kit (C-TEK), a ruggedized, all-in-one mobile forensics field kit packaged in a standard-size backpack, giving military teams the hardware, software and power to access and analyze devices at the point of capture. D
- Priority Commerce Announces Acquisition of IntelliPay
Priority Technology Holdings, Inc. (NASDAQ:PRTH) ("Priority Commerce" or the "Company") today announced it has entered into a membership interest purchase agreement to acquire IntelliPay, whose software enables government agencies, educational institutions, and healthcare organizations to securely accept and manage payments.The acquisition will establish Priority Commerce Government, extending the company's enterprise payments business into the public sector. Priority Commerce Government is expected to contribute just over $4 million of incremental revenue to Priority Commerce for the balance of 2026."IntelliPay has been a longstanding partner and has built a strong business serving state an
- Jim Fish to Retire from WM; John Morris Named as Next CEO
WM (NYSE:WM) announced that Jim Fish, Chief Executive Officer and a member of the Board of Directors, has advised the Board of his plan to retire from WM and resign from the Board, following more than a decade of distinguished service in those roles and more than 25 years with the company. In continuation of WM’s robust succession planning process, the Board of Directors has appointed WM President John Morris to the position of President and Chief Executive Officer, effective Jan. 4, 2027. Morris will also join the Board of Directors at that time. "John is an exceptional leader with a proven track record of delivering results and advancing WM’s strategy. Over three decades of industry exp
- Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
New patent broadens protection around systems integrating real-time physiological feedback, sensing and imaging with controlled therapeutic delivery, including neural ablation approaches for cancer pain THE WOODLANDS, TX, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the issuance of U.S. Patent No. 12,714,780 by the United States Patent and Trademark Office (USPTO), titled "Systems and Methods for Regulating Organ and/or Tumor Growth Rates, Function, and/or Development" on August 25, 2026. The newly issued patent covers medical sys
- Duos Technologies Group Appoints Christopher DeAlmeida as Chief Financial Officer
JACKSONVILLE, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. ("Duos" or the "Company") (NASDAQ:DUOT), a leading provider of adaptive, modular, and scalable Edge Data Center ("EDC") solutions, announced the appointment of Christopher "Chris" DeAlmeida as Chief Financial Officer ("CFO"), effective Monday, August 24, 2026. Mr. DeAlmeida succeeds retiring CFO Adrian Goldfarb. His appointment follows the Company’s previously disclosed executive transition plan and marks the conclusion of a comprehensive search and evaluation process. As CFO, Mr. DeAlmeida will oversee capital allocation, financial planning, and investment strategy as Duos continues the rapid rollout of i
- How Power Constraints Are Shaping the Future of AI Data Center Growth
AUSTIN, Texas, Aug. 26, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Artificial intelligence is often framed as a purely digital phenomenon, yet its financial reality is grounded in concrete, copper and steel just as much as code. According to International Data Corporation figures, worldwide spending on AI infrastructure is expected to hit approximately $487 billion in 2026 and climb past $1 trillion by 2029, with a large share of that money flowing toward securing land, power and network connectivity rather than semiconductors alone. AZIO AI Holdings Inc. (NASDAQ:AZIO) (profile) is one of the companies aiming to serve this emerging market. The firm is building out Atlas One, t
- Wrap Technologies Inc. (NASDAQ: WRAP) Expands Vital Partnership, Strengthens Position in Key Defense Space
NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- via NetworkNewsWire ("NNW") -- Wrap Technologies Inc. (NASDAQ:WRAP) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the full publication, "The Interception Gap: Directed Energy Solved Cost of Shooting Down Drones, Exposed a Harder Problem Underneath," please visit: https://ibn.fm/S1X3j For most of the past decade, counter-drone defense was framed as a capability
- Limoneira to Announce Third Quarter 2026 Financial Results on September 9, 2026
Company to Host Conference Call at 1:30 pm Pacific Time Limoneira Company (the "Company" or "Limoneira") (NASDAQ:LMNR), a diversified lemon and avocado growing and lemon packing company with related agribusiness activities and real estate development operations, announced today it will release financial results for the third quarter ended July 31, 2026, on Wednesday, September 9, 2026, after the market close. The Company will host a conference call to discuss its financial results on September 9, 2026, at 1:30 pm Pacific Time (4:30 pm Eastern Time). Investors interested in participating in the live call can dial (877) 407-0789 from the U.S. International callers can dial (201) 689-8562.
- Banco Azteca Evolves from Automation to Enterprise-Scale Business Orchestration with UiPath
Mexico’s largest financial institution evolves from automation to fully orchestrated enterprise workflows, scaling thousands of processes, hundreds of automations, and delivering an improved customer experience UiPath, Inc. (NYSE:PATH), a leader in business orchestration and automation, today announced that Banco Azteca, one of Mexico's largest financial institutions, transformed its automation program using UiPath Maestro™, orchestrating complex, end-to-end business processes across more than 8,800 enterprise processes and more than 300 automations. Using a single, governed operating model, Banco Azteca can coordinate people, AI agents, systems, and third-party partners, improving visibi
- Fans Score More: NFL Extra Points American Express® Credit Card Now Available
Bread Financial® to continue as issuer for the NFL Extra Points Credit Card program, with majority of clubs transitioning to the American Express Network NEW YORK and COLUMBUS, Ohio, Aug. 26, 2026 (GLOBE NEWSWIRE) -- American Express® (NYSE:AXP) and Bread Financial® (NYSE:BFH) today announced that the NFL Extra Points Credit Card program has launched on the American Express Network. NFL Extra Points American Express® Credit Cardholders now have access to American Express Network benefits, offers, experiences and protections. The NFL and Bread Financial have also introduced refreshed card designs across the NFL team lineup, giving fans a new way to show their team loyalty. This builds on
- Swvl Announces Pricing of $1.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules Upsizing Its Strategic Round to $14.5 Million
DUBAI, United Arab Emirates, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Swvl Holdings Corp (NASDAQ:SWVL) ("Swvl" or the "Company"), a leading provider of technology-driven mobility solutions for enterprises and governments, today announced its entry into a definitive agreement with Sofico Holdings Limited ("Sofico", or the "Purchaser"), to purchase $1.5 million of ordinary shares in a private placement, at a purchase price of $1.46 per share (the "Offering"). The Purchaser has agreed to lock up the securities purchased in the Offering for a period of 6 months, and also agreed to transfer less than 20% of the securities purchased in the Offering for each 90-day period thereafter in an amount not exc
- DeFi Development Corp. Launches State of Solana, a Real-Time Intelligence Platform for the Solana Ecosystem
BOCA RATON, FL, Aug. 26, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (NASDAQ:DFDV) (the "Company"), the first U.S. public company with a treasury strategy built around accumulating and compounding Solana (SOL), today announced the launch of State of Solana, a new public data and research platform designed to make it easier for investors, builders, and ecosystem participants to track the health and growth of Solana in real time. State of Solana is available at https://stateofsol.com/. The platform consolidates a wide range of Solana market, network, staking, and ecosystem data into a single dashboard, giving users a more comprehensive view of Solana beyond the price of SOL. State of
- Bel Fuse Announces Participation in Citi’s 2026 Global TMT Conference
WEST ORANGE, N.J., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Bel Fuse Inc. (NASDAQ:BELFA), a global designer, manufacturer, and provider of critical electronic components, systems and solutions for customers in aerospace, defense, industrial, and data-driven markets, today announced its participation in Citi’s 2026 Global TMT Conference. Citi’s 2026 Global TMT ConferenceLynn Hutkin, CFOThursday, September 10, 2026Hilton Hotel, New York Conducting meetings throughout the day with a fireside chat at 8:10am ET The investor presentation deck and webcast will be accessible via the investor relations section of the website at: https://ir.belfuse.com/events-and-presentations. About BelBel (www.belfuse
- IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001
Leading oncology experts and company management will discuss the Phase 3 OVATION 3 study, supporting science and data, clinical progress, and upcoming milestones A patient treated with IMNN-001 will share firsthand perspective on her treatment journey and life following participation in the clinical trial The event will be held on September 23 in New York City and will be webcast live LAWRENCEVILLE, N.J., Aug. 26, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ:IMNN), a clinical-stage biotechnology company developing IMNN-001 DNA-mediated IL-12 immunotherapy, today announced that it will host an R&D Day for investors, analysts and media on Wednesday, September 23, 2026, at the Sofitel New
- SEALSQ’s Subsidiary ICAlps Advances QASIC Roadmap for Sovereign, Quantum-Resistant Application-Specific Integrated Circuits
Geneva, Switzerland, Aug. 26, 2026 (GLOBE NEWSWIRE) -- QASIC initially targets the cybersecurity, medical and automotive sectors by combining SEALSQ’s post-quantum security technologies with IC’Alps’ advanced custom-chip design capabilities SEALSQ Corp (NASDAQ:LAES) ("SEALSQ" or the "Company"), a global leader in post-quantum semiconductor, Public Key Infrastructure ("PKI") and digital identity technologies, today provided an update on the development of QASIC, its Quantum-Resistant Application-Specific Integrated Circuit initiative. Developed through IC’Alps, SEALSQ’s French ASIC design subsidiary, QASIC combines SEALSQ’s post-quantum cryptography ("PQC") and secure-semiconductor tech